Delivery Order SPE2DR25D3005-SPE2DR26FP9LE
Award Date 2/18/26
Potential Completion Date 2/19/26
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $14,309.38 delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for Actemra Actpen 162 mg/0.9 ml injectable pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order has a ceiling value of $14,309.38 with an ultimate completion date of February 3, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- The Defense Logistics Agency issued a $10,674.71 delivery order to Amerisourcebergen Drug Corp on February 3, 2026, for Actemra 162 mg/0.9 ml syringe supply. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 4, 2026, and is priced on a firm fixed-price basis with no set-aside applied. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a single-award indefinite delivery contract valued at $999,999,999.00 and running...
- <p>The Defense Logistics Agency issued a $3,003.48 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $3,003.48 with firm fixed pricing. Ultimate completion date is February 18, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, with a ceiling value of $8,986.71 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA. The ultimate completion date is February 3, 2026. Pricing is firm fixed price. The order was issued under a non-set-aside basis. This delivery order is called against the company's parent IDC with DLA Troop Support Medical, a $999.999 million indefinite...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $58,983.31 for supply of Actemra 162 mg/0.9 mL syringes. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,485.10 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA 19428. The order matures February 10, 2026. This is a firm fixed-price delivery order issued under no set-aside. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract held by Cencora, Inc. (parent of the awardee), valued at...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Actemra Actpen 162 mg/0.9 ml auto-injector pharmaceutical product, with a ceiling value of $15,620.70.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of February 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $19,253.01 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,003.48 to Amerisourcebergen Drug Corp on January 6, 2026, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,111.54 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The contract, which is a child delivery order under a larger indefinite delivery vehicle, was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will take place at...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP9LEDelivery Order
The Defense Logistics Agency issued a $5,237.78 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical supply. The order is placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate completion date is February 19, 2026. Pricing is firm fixed price. No set-aside was used.
Generated 5/19/26, 10:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 2/17/26 |